By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

Tobira Therapeutics Inc. 

214 Carnegie Center
Suite 306
Princeton  New Jersey  08540  U.S.A.
Phone: 609-897-1102 Fax: n/a


SEARCH JOBS








Company News
Bay Area Biotech Firm Tobira Therapeutics Inc. Tables $74 Million IPO 8/7/2014 3:15:50 PM
South San Francisco's Tobira Therapeutics Inc. Wraps Up $15 Million Loan Agreement 7/1/2014 7:05:52 AM
Tobira Therapeutics Inc. Adds To Its Board Of Directors 6/23/2014 8:15:16 AM
Tobira Therapeutics Inc. Appoints Chairman Laurent Fischer, MD, Chief Executive Officer And Christopher Peetz Chief Financial Officer 3/26/2014 1:20:31 PM
Tobira Therapeutics Inc. Presents Data Supporting Anti-Fibrotic Activity of Cenicriviroc in Liver Disease Models at The Liver Meeting 2013 11/4/2013 6:43:07 AM
Tobira Therapeutics Inc. Presents Positive 48-Week Data From Phase 2b Trial of Cenicriviroc in Treatment-Naïve HIV Infection at the 14th European AIDS Conference 10/17/2013 7:08:04 AM
Tobira Therapeutics Inc. Announces Publication of Cenicriviroc Formulation Improvement Providing Platform for Single Tablet and Fixed-Dose Combinations 10/4/2013 9:54:09 AM
Tobira Therapeutics Inc. Presents Positive Phase 2b Clinical Results for Cenicriviroc in Treatment-Naïve HIV Infection in Late Breaker Session at CROI 3/5/2013 1:49:37 PM
Tobira Therapeutics Inc. Announces Positive 24-Week Primary Analysis From Phase 2b Trial of Cenicriviroc in Treatment-Naïve HIV Infection 1/7/2013 10:30:05 AM
Tobira Therapeutics Inc. to Present at the 31st Annual J. P. Morgan Healthcare Conference 12/19/2012 7:12:07 AM
1234
//-->